Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -10.72%4.35B | 20.50%11.58B | 15.85%4.87B | 22.00%9.61B | --4.21B | 28.28%7.88B | 67.63%6.14B | 75.85%2.43B | 39.70%3.66B | --1.38B |
| Operating income | -10.72%4.35B | 20.50%11.58B | 15.85%4.87B | 22.00%9.61B | 4.21B | 28.28%7.88B | 67.63%6.14B | 75.85%2.43B | 39.70%3.66B | 1.38B |
| Cost of sales | -2.91%-3.41B | -33.46%-7.81B | -19.61%-3.31B | -23.28%-5.85B | ---2.77B | -43.99%-4.74B | -63.52%-3.3B | -77.84%-1.37B | -56.96%-2.02B | ---767.96M |
| Operating expenses | -2.91%-3.41B | -33.46%-7.81B | -19.61%-3.31B | -23.28%-5.85B | -2.77B | -43.99%-4.74B | -63.52%-3.3B | -77.84%-1.37B | -56.96%-2.02B | -767.96M |
| Gross profit | -39.67%940.67M | 0.35%3.77B | 8.58%1.56B | 20.06%3.76B | 1.44B | 10.09%3.13B | 72.65%2.85B | 73.36%1.06B | 23.15%1.65B | 613.75M |
| Selling expenses | 7.70%-242.51M | -17.95%-608.68M | -116.00%-262.74M | -51.42%-516.06M | ---121.64M | 24.58%-340.8M | -65.46%-451.85M | -91.54%-195.52M | -47.30%-273.09M | ---102.07M |
| Administrative expenses | -22.76%-519.91M | -17.97%-1.27B | 2.86%-423.51M | -24.73%-1.08B | ---435.97M | -15.87%-863.78M | -81.19%-745.46M | -87.15%-272.39M | -2.81%-411.42M | ---145.55M |
| Impairment and provision | 209.21%186.88M | 62.12%-107.37M | -2.21%-171.12M | -157.43%-283.47M | ---167.42M | 63.81%-110.11M | -231.50%-304.29M | 61.75%-27.72M | 10.57%-91.79M | ---72.48M |
| -Other impairment is provision | 209.21%186.88M | 62.12%-107.37M | -2.21%-171.12M | -157.43%-283.47M | ---167.42M | 63.81%-110.11M | -231.50%-304.29M | 61.75%-27.72M | 10.57%-91.79M | ---72.48M |
| Special items of operating profit | -0.94%86.21M | 23.99%218.43M | 7.19%87.03M | 56,363.46%176.17M | --81.2M | -99.85%312K | 183.90%208.47M | -151.93%-17.24M | 31.87%73.43M | --33.21M |
| Operating profit | -42.79%451.35M | -2.65%2.01B | -0.42%788.99M | 13.31%2.06B | 792.32M | 17.12%1.82B | 64.23%1.55B | 68.62%551.14M | 33.92%945.49M | 326.86M |
| Financing cost | -4.97%-401.07M | 3.40%-805.83M | 15.95%-382.1M | 9.80%-834.16M | ---454.62M | -42.21%-924.82M | -113.93%-650.32M | -86.00%-245.78M | -29.80%-303.98M | ---132.14M |
| Earning before tax | -87.64%50.28M | -2.15%1.2B | 20.49%406.89M | 37.23%1.23B | 337.7M | -0.96%893.8M | 40.68%902.5M | 56.82%305.36M | 35.97%641.51M | 194.72M |
| Tax | 89.34%-14.79M | -15.04%-303.84M | -37.90%-138.66M | -15.10%-264.12M | ---100.56M | -18.98%-229.47M | -30.18%-192.86M | -60.75%-71.73M | -61.92%-148.15M | ---44.62M |
| After-tax profit from continuing operations | -86.77%35.49M | -6.87%896.32M | 13.11%268.23M | 44.87%962.41M | 237.14M | -6.38%664.34M | 43.84%709.64M | 55.65%233.63M | 29.72%493.36M | 150.1M |
| Earning after tax | -86.77%35.49M | -6.87%896.32M | 13.11%268.23M | 44.87%962.41M | 237.14M | -6.38%664.34M | 43.84%709.64M | 55.65%233.63M | 29.72%493.36M | 150.1M |
| Minority profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -32.59%44.99M | --13.47M |
| Profit attributable to shareholders | -86.77%35.49M | -6.87%896.32M | 13.11%268.23M | 44.87%962.41M | 237.14M | -6.38%664.34M | 58.27%709.64M | 70.99%233.63M | 42.98%448.37M | 136.63M |
| Basic earnings per share | -87.50%0.01 | -12.50%0.28 | 0.00%0.08 | 39.13%0.32 | 0.08 | 0.23 | ||||
| Diluted earnings per share | -87.50%0.01 | -12.50%0.28 | 0.00%0.08 | 39.13%0.32 | 0.08 | 0.23 | ||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.